ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $14,800,000 | +48.9% | 607,070 | -12.9% | 1.73% | +52.4% |
| Q4 2018 | $9,938,000 | -14.9% | 697,370 | -9.2% | 1.14% | -2.9% |
| Q3 2018 | $11,679,000 | -3.8% | 768,370 | +6.2% | 1.17% | -5.8% |
| Q2 2018 | $12,138,000 | +6.0% | 723,370 | +3.1% | 1.24% | -12.0% |
| Q1 2018 | $11,448,000 | +77.8% | 701,470 | +39.4% | 1.41% | +62.2% |
| Q4 2017 | $6,439,000 | -19.5% | 503,059 | -22.6% | 0.87% | -14.8% |
| Q3 2017 | $7,995,000 | +124.8% | 650,000 | +52.9% | 1.02% | +99.8% |
| Q2 2017 | $3,557,000 | +13.7% | 425,000 | +21.4% | 0.51% | +3.0% |
| Q1 2017 | $3,129,000 | -35.3% | 350,000 | -36.4% | 0.50% | -46.5% |
| Q4 2016 | $4,835,000 | -99.9% | 550,000 | 0.0% | 0.93% | +57.1% |
| Q3 2016 | $3,712,500,000 | +281790.7% | 550,000 | +48.6% | 0.59% | +152.1% |
| Q2 2016 | $1,317,000 | +20.6% | 370,000 | 0.0% | 0.23% | +7.8% |
| Q1 2016 | $1,092,000 | -30.0% | 370,000 | 0.0% | 0.22% | -8.1% |
| Q4 2015 | $1,561,000 | -7.5% | 370,000 | 0.0% | 0.24% | -12.3% |
| Q3 2015 | $1,687,000 | -36.8% | 370,000 | 0.0% | 0.27% | -15.9% |
| Q2 2015 | $2,668,000 | -9.5% | 370,000 | -7.5% | 0.32% | -35.6% |
| Q1 2015 | $2,948,000 | +14.4% | 400,000 | -26.6% | 0.50% | -33.5% |
| Q4 2014 | $2,578,000 | +90.4% | 545,000 | +43.7% | 0.75% | +88.6% |
| Q3 2014 | $1,354,000 | -9.8% | 379,199 | +15.2% | 0.40% | -11.0% |
| Q2 2014 | $1,501,000 | -3.0% | 329,199 | 0.0% | 0.44% | -4.1% |
| Q1 2014 | $1,547,000 | -14.2% | 329,199 | -8.6% | 0.46% | -34.3% |
| Q4 2013 | $1,804,000 | – | 360,000 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |